NCT05632211View on ClinicalTrials.gov

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

December 16, 2022

Primary Completion Date

October 3, 2023

Study Completion Date

October 3, 2023

Conditions
Healthy Adult Subjects
Interventions
BIOLOGICAL

AVT05

Pre filled syringes filled with AVT05

BIOLOGICAL

Simponi

Pre filled syringes filled with Simponi

Trial Locations (2)

8011

New Zealand Clinical Research, Christchurch

Unknown

Richmond Pharmacology Ltd, London

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Alvotech Swiss AG

INDUSTRY